Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 3
2004 5
2005 6
2006 10
2007 12
2008 11
2009 8
2010 13
2011 6
2012 10
2013 15
2014 12
2015 17
2016 13
2017 8
2018 12
2019 11
2020 28
2021 8
2022 10
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Results by year

Filters applied: . Clear all
Page 1
Recurrent Takotsubo Syndrome: How Frequent, and How Does It Present?
Looi JL, Easton A, Webster M, To A, Lee M, Kerr AJ. Looi JL, et al. Among authors: webster m. Heart Lung Circ. 2024 Mar 29:S1443-9506(24)00124-0. doi: 10.1016/j.hlc.2024.02.008. Online ahead of print. Heart Lung Circ. 2024. PMID: 38555187
First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with de novo coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCT.
Saito S, Bennett J, Nef HM, Webster M, Namiki A, Takahashi A, Kakuta T, Yamazaki S, Shibata Y, Scott D, Vrolix M, Menon M, Möllmann H, Werner N, Neylon A, Mehmedbegovic Z, Smits PC, Morice MC, Verheye S; BIOADAPTOR-RCT Collaborators. Saito S, et al. Among authors: webster m. EClinicalMedicine. 2023 Oct 24;65:102304. doi: 10.1016/j.eclinm.2023.102304. eCollection 2023 Nov. EClinicalMedicine. 2023. PMID: 38106564 Free PMC article.
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years.
Mack MJ, Leon MB, Thourani VH, Pibarot P, Hahn RT, Genereux P, Kodali SK, Kapadia SR, Cohen DJ, Pocock SJ, Lu M, White R, Szerlip M, Ternacle J, Malaisrie SC, Herrmann HC, Szeto WY, Russo MJ, Babaliaros V, Smith CR, Blanke P, Webb JG, Makkar R; PARTNER 3 Investigators. Mack MJ, et al. N Engl J Med. 2023 Nov 23;389(21):1949-1960. doi: 10.1056/NEJMoa2307447. Epub 2023 Oct 24. N Engl J Med. 2023. PMID: 37874020 Clinical Trial.
DynamX sirolimus-eluting Bioadaptor versus the zotarolimus-eluting Resolute Onyx stent in patients with de novo coronary artery lesions: Design and rationale of the multi-center, international, randomized BIODAPTOR-RCT.
Saito S, Nef HM, Webster M, Verheye S; DynamX RCT investigators. Saito S, et al. Among authors: webster m. Cardiovasc Revasc Med. 2023 Oct;55:76-82. doi: 10.1016/j.carrev.2023.05.010. Epub 2023 May 23. Cardiovasc Revasc Med. 2023. PMID: 37479544 Clinical Trial.
206 results